ArticleOncology letters2021

MMP12 is a potential therapeutic target for Adamantinomatous craniopharyngioma: Conclusions from bioinformatics analysis and

Minde Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.